Home LiteratureArticle Details
PMID: 11880515 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH

Abstract

Transgenic mice expressing mutant amyloid precursor proteins (APPs) have provided important new information about the pathogenesis of Alzheimer's disease (AD) histopathology. However, the molecular basis of memory loss in these mice is poorly understood. One of the major impediments has been the difficulty of distinguishing between age-dependent and age-independent behavioral changes. To address this issue we studied in parallel two lines of APP transgenic mice expressing comparable levels of mutant and wild-type human APP. This enabled us to identify age-independent behavioral deficits that were not specifically related to mutant APP expression. When mice with age-independent deficits were eliminated, we detected memory loss in transgenic mice expressing mutant APP (Tg2576 mice) starting at approximately 6 months, which coincided with the appearance of detergent-insoluble Abeta aggregates (Abeta(insol)). Genetically accelerating the formation of Abeta(insol) resulted in an earlier onset of memory decline. A facile interpretation of these results, namely that memory loss and Abeta(insol) were closely connected, was rejected when we extended our analysis to include older mice. No obvious correspondence between memory and Abeta(insol) was apparent in a combined group of old and young mice unless the mice were stratified by age, whereupon inverse correlations between memory and Abeta(insol) became evident. These results suggested that Abeta(insol) is a surrogate marker for small assemblies of Abeta that disrupt cognition and occur as intermediates during Abeta(insol) formation, and they are the first descriptive in vivo data supporting their role in impairing memory. These studies also provide a methodological framework within which to investigate these Abeta assemblies in vivo.

MeSH Terms
Age Factors Aging Alzheimer Disease/complications,genetics,physiopathology Amino Acid Substitution Amyloid beta-Peptides/chemistry,genetics,metabolism Amyloid beta-Protein Precursor/genetics Animals Behavior, Animal Biomarkers/analysis Detergents/chemistry Disease Models, Animal Disease Progression Humans Macromolecular Substances Maze Learning Membrane Proteins/biosynthesis,genetics Memory Disorders/etiology,pathology,physiopathology Mice Mice, Transgenic Mutation Presenilin-1 Solubility Time Factors
Chemicals
Amyloid beta-Peptides Amyloid beta-Protein Precursor Biomarkers Detergents Macromolecular Substances Membrane Proteins PSEN1 protein, human Presenilin-1
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Westerman Marcus A
Department of Neurology, Center for Clinical and Molecular Neurobiology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Cooper-Blacketer Deirdre
Mariash Ami
Kotilinek Linda
Kawarabayashi Takeshi
Younkin Linda H
Carlson George A
Younkin Steven G
Ashe Karen H
References (49)
49 references, click to expand
  1. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
    Ann Neurol. 1991 Oct;30(4):572-80 PMID: 1789684
  2. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
    J Neurosci. 2000 Jun 1;20(11):4050-8 PMID: 10818140
  3. Purification and cloning of amyloid precursor protein beta-secretase from human brain.
    Nature. 1999 Dec 2;402(6761):537-40 PMID: 10591214
  4. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53 PMID: 9600986
  5. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).
    J Biol Chem. 1995 Mar 31;270(13):7013-6 PMID: 7706234
  6. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.
    Behav Genet. 1999 May;29(3):177-85 PMID: 10547924
  7. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Science. 1999 Oct 22;286(5440):735-41 PMID: 10531052
  8. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway.
    Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5280-5 PMID: 10220457
  9. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.
    Science. 1994 May 27;264(5163):1336-40 PMID: 8191290
  10. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1550-5 PMID: 9037091
  11. Developments of a water-maze procedure for studying spatial learning in the rat.
    J Neurosci Methods. 1984 May;11(1):47-60 PMID: 6471907
  12. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
    Ann Neurol. 1988 Feb;23(2):138-44 PMID: 2897823
  13. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.
    Nature. 1996 Oct 24;383(6602):710-3 PMID: 8878479
  14. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.
    Neurobiol Aging. 1996 Nov-Dec;17(6):921-33 PMID: 9363804
  15. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.
    Nat Med. 1998 Jan;4(1):97-100 PMID: 9427614
  16. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Nature. 2000 Dec 21-28;408(6815):982-5 PMID: 11140686
  17. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.
    Neuron. 1995 Nov;15(5):1203-18 PMID: 7576662
  18. Chimeric prion protein expression in cultured cells and transgenic mice.
    Protein Sci. 1992 Aug;1(8):986-97 PMID: 1338978
  19. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.
    Exp Neurol. 1999 Aug;158(2):328-37 PMID: 10415140
  20. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.
    Behav Brain Res. 1999 Sep;103(2):145-62 PMID: 10513583
  21. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.
    J Neuropathol Exp Neurol. 1997 Sep;56(9):965-73 PMID: 9291938
  22. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    JAMA. 2000 Mar 22-29;283(12):1571-7 PMID: 10735393
  23. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.
    Nature. 2000 Dec 21-28;408(6815):975-9 PMID: 11140684
  24. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze.
    Behav Neurosci. 1993 Aug;107(4):618-26 PMID: 8397866
  25. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
    Nat Med. 1997 Jan;3(1):67-72 PMID: 8986743
  26. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.
    J Neurosci Methods. 1999 Feb 1;87(1):87-95 PMID: 10065997
  27. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.
    Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12683-8 PMID: 9770546
  28. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease.
    J Neuropathol Exp Neurol. 1997 May;56(5):531-40 PMID: 9143266
  29. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.
    J Neurosci. 1999 Oct 15;19(20):8876-84 PMID: 10516307
  30. Alzheimer's disease: genes, proteins, and therapy.
    Physiol Rev. 2001 Apr;81(2):741-66 PMID: 11274343
  31. Identification of normal and pathological aging in prospectively studied nondemented elderly humans.
    Neurobiol Aging. 1992 Jan-Feb;13(1):179-89 PMID: 1311804
  32. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33 PMID: 10077666
  33. Caloric restriction and spatial learning in old mice.
    Physiol Behav. 1996 Aug;60(2):541-7 PMID: 8840916
  34. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.
    Science. 1993 Jan 22;259(5094):514-6 PMID: 8424174
  35. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.
    Science. 1996 Oct 4;274(5284):99-102 PMID: 8810256
  36. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice.
    Neurobiol Aging. 2001 May-Jun;22(3):377-85 PMID: 11378242
  37. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.
    Neurology. 1992 Mar;42(3 Pt 1):631-9 PMID: 1549228
  38. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.
    J Biol Chem. 2001 Jun 15;276(24):21562-70 PMID: 11279122
  39. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.
    Arch Neurol. 1993 Apr;50(4):349-58 PMID: 8460956
  40. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.
    Biochim Biophys Acta. 2000 Jul 26;1502(1):172-87 PMID: 10899442
  41. Amyloid deposition as the central event in the aetiology of Alzheimer's disease.
    Trends Pharmacol Sci. 1991 Oct;12(10):383-8 PMID: 1763432
  42. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.
    J Biol Chem. 1996 Aug 23;271(34):20631-5 PMID: 8702810
  43. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    J Neurosci. 2001 Jan 15;21(2):372-81 PMID: 11160418
  44. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Nature. 1995 Feb 9;373(6514):523-7 PMID: 7845465
  45. Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person.
    Neurosci Lett. 1990 Aug 14;116(1-2):87-93 PMID: 2259457
  46. Effects of aging on spatial learning and hippocampal protein kinase C in mice.
    Neurobiol Aging. 1993 Jul-Aug;14(4):309-17 PMID: 8367012
  47. Formation of beta-amyloid protein deposits in brains of transgenic mice.
    Nature. 1991 Jul 18;352(6332):239-41 PMID: 1906990
  48. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7450-4 PMID: 8052602
  49. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.
    Nat Neurosci. 1999 Mar;2(3):271-6 PMID: 10195221
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2002-03-01
Pages
1858-67
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6758862
Subset
IM
Grants
NIA NIH HHS · P01 AG015453 · United States
NINDS NIH HHS · R01 NS033249 · United States
NIA NIH HHS · AG15453 · United States
NINDS NIH HHS · NS33249 · United States
NIMH NIH HHS · MH11834 · United States
NIMH NIH HHS · F31 MH011834 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com